Silent Cerebral Small-Vessel Disease Is Twice as Prevalent in Middle-Aged Individuals With Well-Controlled, Combination Antiretroviral Therapy–Treated Human Immunodeficiency Virus (HIV) Than in HIV-Uninfected Individuals
Author(s) -
Antoine Moulignier,
Julien Savatovsky,
Lambert Assoumou,
François-Xavier Lescure,
C. Lamirel,
O. Godin,
Nadia Valin,
Roland Tubiana,
Ana Canestri,
Pascal Roux,
JeanClaude Sadik,
Laurence Salomon,
Marie Abrivard,
Christine Katlama,
Yazdan Yazdanpanah,
Gilles Pialoux,
PierreMarie Girard,
Dominique Costagliola,
Corinne Amiel,
I. Cochereau,
J. Capeau,
Philippe Girard,
FrançoisXavier Lescure,
Lucie Marchand,
Mikaël Mazighi,
Martine Obadia,
Michel Pâques,
Emmanuelle Plaisier,
P. Yéni,
Angelika Alonso,
Pierre Koskas,
Letícia Barroquelo Viana Lopes,
PierreYves Le Roux,
Virginie Vasseur,
M. Chansombat,
Roland Landman,
Bao-Chau Phung,
Djamila Rahli,
L Lenclume,
MarcAntoine Valantin,
J.L. Meynard,
Manuela Sébire,
A Adda Liévin,
J.P. Bastard,
Soraya Fellahi,
Marie Gisèle Lebrette,
P Thibaut,
Georges Dos Santos,
Jean-Paul Vincensini
Publication year - 2017
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/cix1075
Subject(s) - medicine , hyperintensity , odds ratio , immunology , pediatrics , magnetic resonance imaging , gastroenterology , radiology
Silent cerebral small-vessel disease (CSVD) is defined as white matter hyperintensities, silent brain infarction, or microbleeds. CSVD is responsible for future vascular events, cognitive impairment, frailty, and shorter survival. CSVD prevalence among middle-aged people living with well-controlled human immunodeficiency virus (HIV) infection (PLHIV) is unknown.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom